The "other" signaling of trastuzumab: Antibodies are immunocompetent drugs

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1778-1780
Number of pages3
JournalJournal of Clinical Oncology
Volume26
Issue number11
DOIs
Publication statusPublished - 2008

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

The "other" signaling of trastuzumab : Antibodies are immunocompetent drugs. / Gianni, Luca.

In: Journal of Clinical Oncology, Vol. 26, No. 11, 2008, p. 1778-1780.

Research output: Contribution to journalArticle

@article{9ef5e14295e14e29a572426c2c05cd4e,
title = "The {"}other{"} signaling of trastuzumab: Antibodies are immunocompetent drugs",
author = "Luca Gianni",
year = "2008",
doi = "10.1200/JCO.2007.15.7404",
language = "English",
volume = "26",
pages = "1778--1780",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "11",

}

TY - JOUR

T1 - The "other" signaling of trastuzumab

T2 - Antibodies are immunocompetent drugs

AU - Gianni, Luca

PY - 2008

Y1 - 2008

UR - http://www.scopus.com/inward/record.url?scp=42949108274&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=42949108274&partnerID=8YFLogxK

U2 - 10.1200/JCO.2007.15.7404

DO - 10.1200/JCO.2007.15.7404

M3 - Article

C2 - 18347004

AN - SCOPUS:42949108274

VL - 26

SP - 1778

EP - 1780

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 11

ER -